参考文献/References:
[1]Melissaropoulos K,Bogdanos D,Dimitroulas T,et al.Primary Sjgren’s Syndrome and Cardiovascular Disease[J].Current Vascular Pharmacology,2020,18(5):447-454.[2]Jin L,Yu D,Li X,et al.CD4+CXCR5+ follicular helper T cells in salivary gland promote B cells maturation in patients withprimary Sjogren’s syndrome[J].Clin Exp Pathol,2014,7(5):1988-1996.[3]Odani T,Chiorini JA.Targeting primary Sjogren’s syndrome[J].Mod Rheumatol,2019,29(1):70-86.[4]Voigt A,Esfandiary L,Wanchoo A,et al.Sexual dimorphic function of IL-17 in salivary gland dysfunction of the C57BL/6.NOD-Aec1Aec2 model of Sjogren’s syndrome[J].Sci Rep,2016(6):38717. [5]Zhang LW,Zhou PR,Wei P,et al.Expression of Interleukin-17 in Primary Sjogren’s Syndrome and the Correlation with Disease Severity:A Systematic Review and Meta-Analysis[J].Scandinavian Journal of Immunology,2018,87(4):e12649.[6]Lin X,Rui K,Deng J,et al.Th17 cells play a critical role in the development of experimental Sjgren’s syndrome[J].Annals of the Rheumatic Diseases,2014,74(6):1302-1310.[7]Sumida T,Tsuboi H,Iizuka M,et al.The role of M3 muscarinic acetylcholine receptor reactive T cells in Sjgren’s syndrome:A critical review[J].Journal of Autoimmunity,2014(51):44-50.[8]Hao LR,Li XF,Gao C,et al.Th17/Treg cell level and clinical characteristics of peripheral blood of patients with Sjogren’s syndrome complicated with primary biliary cirrhosis[J].Medicine,2019,98(24):e15952.[9]Chen X,Jiang S,Zhou Z,et al.Increased expression of interleukin-21-inducible genes in minor salivary glands are associated with primary Sjgren’s syndrome disease characteristics[J].Rheumatology,2020,60(6):2979-2989.[10]Voigt A,Bohn K,Sukumaran S,et al.Unique glandular ex-vivo Th1 and Th17 receptor motifs in Sjgren’s syndrome patients using single-cell analysis[J].Clinical Immunology,2018,69(10):58-67.[11]Luo D,Chen Y,Zhou N,et al.Blockade of Th17 response by IL-38 in primary Sjgren’s syndrome[J].Molecular Immunology,2020(127):107-111.[12]Attridge K,Wang CJ,Wardzinski L,et al.IL-21 inhibits T cell IL-2 production and impairs Treg homeostasis[J].Blood,2012,119(20):4656-4664.[13]Long D,Chen Y,Wu H,et al.Clinical significance and immunobiology of IL-21 in autoimmunity[J].Journal of Autoimmunity,2019(99):1-14.[14]Cano-Ortiz A,Laborda-Illanes A,Plaza-Andrades I,et al.Connection between the Gut Microbiome,Systemic Inflammation,Gut Permeability and FOXP3 Expression in Patients with Primary Sjgren’s Syndrome[J].International Journal of Molecular Sciences,2020,21(22):8733.[15]Liu C,Guan Z,Zhao L,et al.Elevated level of circulating CD4+Helios+FoxP3+ cells in primary Sjogren’s syndrome patients[J].Modern Rheumatology,2017,27(4):630-637.[16]Miao M,Hao Z,Guo Y,et al.Short-term and low-dose IL-2 therapy restores the Th17/Treg balance in the peripheral blood of patients with primary Sjgren’s syndrome[J].Annals of the Rheumatic Diseases,2018,77(12):1838-1840. [17]Zheng X,Wang Q,Yuan x,et al.B7-H4 Inhibits the Development of Primary Sjgren’s Syndrome by Regulating Treg Differentiation in NOD/Ltj Mice[J].Journal of Immunology Research,2020,2020(1):4896727.[18]Farahnik B,Beroukhim K,Abrouk M,et al.Brodalumab for the Treatment of Psoriasis:A Review of Phase III Trials[J].Dermatology&Therapy,2016,6(2):111-124.[19]Baeten D,Sieper J,Braun J,et al.Secukinumab,an Interleukin-17A Inhibitor,in Ankylosing Spondylitis[J].Engl Med,2015,373(26):2534-2548. [20]Reich K,Puig L,Mallbris L,et al.The effect of bodyweight on the efficacy and safety of ixekizumab: results from an integrated database of three randomised,controlled Phase 3 studies of patients with moderate‐to‐severe plaque psoriasis[J].Journal of the European Academy of Dermatology&Venereology Jeadv,2017,31(7):1196-1207.[21]Fusconi M,Musy I,Valente D,et al.Immunohistochemical detection of IL-17 and IL-23 improves the identification of patients with a possible diagnosis of Sjogren’s syndrome[J].Pathology Research and Practice,2020,216(11):153137.[22]Bilal J,Berlinberg A,Bhattacharjee S,et al.A Systematic Review and Meta-Analysis of the Efficacy and Safety of the Interleukin(IL)-12/23 and IL-17 Inhibitors Ustekinumab, Secukinumab,Ixekizumab,Brodalumab,Guselkumab,and Tildrakizumab for the Treatment of Moderate to Severe Plaque Psoriasis[J].Journal of Dermatological Treatment,2018,29(6):569-578.[23]Kavanaugh A,Ritchlin C,Rahman P,et al.Ustekinumab,an anti-IL-12/23 p40 monoclonal antibody,inhibits radiographic progression in patients with active psoriatic arthritis:results of an integrated analysis of radiographic data from the phase 3,multicentre,randomised,double-blind,placebo-co[J].Annals of the Rheumatic Diseases:A Journal of Clinical Rheumatology and Connective Tissue Research,2014,73(6):1000-1006.[24]Manfrè V,Cafaro G,Riccucci I,et al.One year in review 2020:comorbidities,diagnosis and treatment of primary Sjgren’s syndrome[J].Clinical and Experimental Rheumatology,2020,126(4):10-22. [25]Chimenti MS,Talamonti M,Novelli L,et al.Long-term ustekinumab therapy of psoriasis in patients with coexisting rheumatoid arthritis and Sjogren syndrome.Report of two cases and review of literature[J].Journal of Dermatological Case Reports,2015,9(3):71-75.[26]郑绍勇,程绍民,王朝晖,等.干燥综合征肝肾阴虚证方药运用规律研究[J].江西中医学院学报,2019,31(2):36-38.[27]马武开,和秀丽,曾苹,等.润燥灵方对干燥综合征模型小鼠血清Thl/Th2的影响[J].中医杂志,2017,58(4):329-333.[28]欧永胜,陆静安,薛鸾.薛鸾运用解毒通络生津法治疗干燥综合征经验[J].中国中医基础医学杂志,2020,26(3):394-396.[29]杨月,李奔,陈月恩,等.桑珠滋阴口服液治疗原发性干燥综合征的随机、双盲、安慰剂对照研究[J].中国中医药科技,2017,24(4):456-458.
相似文献/References:
[1]潘 婷,胡阳黔.Th17细胞在非酒精性脂肪肝病炎症过程中的作用[J].医学信息,2020,33(18):22.[doi:10.3969/j.issn.1006-1959.2020.18.007]
PAN Ting,HU Yang-qian.The Role of Th17 Cells in the Inflammatory Process of Non-alcoholic Fatty Liver Disease[J].Medical Information,2020,33(18):22.[doi:10.3969/j.issn.1006-1959.2020.18.007]
[2]潘玫君,杨 兵,曾以敏,等.原发性干燥综合征解毒化瘀方药配伍规律数据挖掘研究[J].医学信息,2023,36(03):1.[doi:10.3969/j.issn.1006-1959.2023.03.001]
PAN Mei-jun,YANG Bing,ZENG Yi-min,et al.Data Mining Research on the Compatibility Rule of Jiedu Huayu Prescriptions for Primary Sj?gren Syndrome[J].Medical Information,2023,36(18):1.[doi:10.3969/j.issn.1006-1959.2023.03.001]
[3]钟伦坤,胡文健,周兴玮,等.清窍胶囊对分泌性中耳炎大鼠Th17、Treg细胞及炎性因子的影响[J].医学信息,2021,34(17):75.[doi:10.3969/j.issn.1006-1959.2021.17.019]
ZHONG Lun-kun,HU Wen-jian,ZHOU Xing-wei,et al.Effect of Qingqiao Capsule on Th17,Treg Cells and Inflammatory Factors in Rats with Secretory Otitis Media[J].Medical Information,2021,34(18):75.[doi:10.3969/j.issn.1006-1959.2021.17.019]